Cargando…
The non-invasive serum biomarker soluble Axl accurately detects advanced liver fibrosis and cirrhosis
Soluble Axl (sAxl) was recently shown to be strongly released into the blood during liver fibrogenesis and hepatocellular carcinoma suggesting sAxl as a biomarker of liver diseases. In this study we are the first to evaluate sAxl in human serum in comparison to Enhanced Liver Fibrosis (ELF) test and...
Autores principales: | Staufer, Katharina, Dengler, Mirko, Huber, Heidemarie, Marculescu, Rodrig, Stauber, Rudolf, Lackner, Carolin, Dienes, Hans-Peter, Kivaranovic, Danijel, Schachner, Christian, Zeitlinger, Markus, Wulkersdorfer, Beatrix, Rauch, Peter, Prager, Gerhard, Trauner, Michael, Mikulits, Wolfgang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5680921/ https://www.ncbi.nlm.nih.gov/pubmed/29072690 http://dx.doi.org/10.1038/cddis.2017.554 |
Ejemplares similares
-
Soluble Axl is an accurate biomarker of cirrhosis and hepatocellular carcinoma development: results from a large scale multicenter analysis
por: Dengler, Mirko, et al.
Publicado: (2017) -
An impaired pituitary–adrenal signalling axis in stable cirrhosis is linked to worse prognosis
por: Hartl, Lukas, et al.
Publicado: (2023) -
Synergism of the receptor tyrosine kinase Axl with ErbB receptors mediates resistance to regorafenib in hepatocellular carcinoma
por: Breitenecker, Kristina, et al.
Publicado: (2023) -
Dynamics of Axl Receptor Shedding in Hepatocellular Carcinoma and Its Implication for Theranostics
por: Holstein, Elisa, et al.
Publicado: (2018) -
Bacterial translocation occurs early in cirrhosis and triggers a selective inflammatory response
por: Simbrunner, Benedikt, et al.
Publicado: (2023)